High frequency of level II-V lymph node involvement in RET/PTC positive papillary thyroid carcinoma

European Journal of Surgical Oncology

Volumn 34, Issue 1, 2008, Pages 77-81

  Wang, Y L ^a   Zhang, R M ^b   Luo, Z W ^b   Wu, Y ^a   Du, X ^a   Wang, Z Y ^a   Zhu, Y X ^a   Li, D S ^a   Ji, Q H ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Gene rearrangement; Lateral neck dissection; Lymphatic metastasis; Multivariate analysis; Papillary thyroid carcinoma; RET

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CANCER SURGERY; CHINESE; CLINICAL DECISION MAKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECTOPIC THYROID GLAND; FEMALE; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC RISK; HASHIMOTO DISEASE; HUMAN; INCIDENCE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE RET; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; THYROID CARCINOMA;

ADULT; CARCINOMA, PAPILLARY; CHINA; FEMALE; HUMANS; LYMPH NODES; MALE; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; RISK FACTORS; THYROID NEOPLASMS;

EID: 37349077614     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.08.012     Document Type: Article

References (29)

1. Fagin J.A. Challenging dogma in thyroid cancer molecular genetics - role of RET/PTC and BRAF in tumor initiation. J Clin Endocrinol Metab 89 (2004) 4264-4266
2. Rubello D., Pelizzo M.R., Al-Nahhas A., et al. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol 32 (2006) 917-921
3. Tallini G., and Asa S.L. RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol 8 (2001) 345-354
4. Klugbauer S., Lengfelder E., Demidchik E.P., and Rabes H.M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 11 (1995) 2459-2467
5. Rabes H.M., Demidchik E.P., Sidorow J.D., et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res 6 (2000) 1093-1103
6. Tallini G., Santoro M., Helie M., et al. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4 (1998) 287-294
7. Di Cristofaro J., Vasko V., Savchenko V., et al. ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients. Endocr Relat Cancer 12 (2005) 173-183
8. Elisei R., Romei C., Vorontsova T., et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86 (2001) 3211-3216
9. Collins B.J., Chiappetta G., Schneider A.B., et al. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 87 (2002) 3941-3946
10. Santoro M., Papotti M., Chiappetta G., et al. RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab 87 (2002) 370-379
11. Lam K.Y., Lo C.Y., and Leung P.S. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas. Eur J Endocrinol 147 (2002) 741-745
12. Lee C.H., Hsu L.S., Chi C.W., Chen G.D., Yang A.H., and Chen J.Y. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas. J Clin Endocrinol Metab 83 (1998) 1629-1632
13. Liu R.T., Chou F.F., Wang C.H., et al. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese. Thyroid 15 (2005) 326-335
14. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
15. Mann B., and Buhr H.J. Lymph node dissection in patients with differentiated thyroid carcinoma - who benefits?. Langenbecks Arch Surg 383 (1998) 355-358
16. Pelizzo M.R., Boschin I.M., Toniato A., et al. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 32 (2006) 1144-1148
17. Zhu X.L., Zhou X.Y., Zhang T.M., and Zhu X.Z. Expressions of wild type-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation. Zhonghua Bing Li Xue Za Zhi 35 (2006) 87-91
18. Teng W., Shan Z., Teng X., et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 354 (2006) 2783-2793
19. Wang J.C., Su C.C., Xu J.B., et al. Novel microdeletion in the transforming growth factor beta type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma. Genes Chromosomes Cancer 46 (2007) 192-201
20. Caron N.R., Tan Y.Y., Ogilvie J.B., et al. Selective modified radical neck dissection for papillary thyroid cancer - is level I, II and V dissection always necessary?. World J Surg 30 (2006) 833-840
21. Palazzo F.F., Gosnell J., Savio R., et al. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol 32 (2006) 340-344
22. Watkinson J.C., Franklyn J.A., and Olliff J.F. Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer. Thyroid 16 (2006) 187-194
23. Machens A., Holzhausen H.J., Lautenschlager C., Thanh P.N., and Dralle H. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Cancer 98 (2003) 712-719
24. Adeniran A.J., Zhu Z., Gandhi M., et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30 (2006) 216-222
25. Salvatore G., Giannini R., Faviana P., et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89 (2004) 5175-5180
26. Zuo H., Tang W., Yasuoka H., et al. A review of 227 cases of small papillary thyroid carcinoma. Eur J Surg Oncol 33 (2007) 370-375
27. Thomas G.A., Bunnell H., Cook H.A., et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84 (1999) 4232-4238
28. Cipolla C., Sandonato L., Graceffa G., et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 71 (2005) 874-878
29. Borrello M.G., Alberti L., Fischer A., et al. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad Sci U S A 102 (2005) 14825-14830